BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2390333)

  • 1. A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
    Vranckx R; Coenjaert A; Muylle L
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):827-30. PubMed ID: 2390333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-II and a new endemic area for HTLV-I in Brazil.
    Moreira Júnior ED; Harrington Júnior W; Ribeiro TT; Melo A; Brites C; Badaró R; Swanson P; Lee H
    Rev Soc Bras Med Trop; 1992; 25(2):141-3. PubMed ID: 1308940
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.
    Pinheiro SR; Carneiro-Proietti AB; Lima-Martins MV; Proietti FA; Pereira AA; Oréfice F
    Rev Soc Bras Med Trop; 1996; 29(4):383-4. PubMed ID: 8768591
    [No Abstract]   [Full Text] [Related]  

  • 5. Low human T cell leukemia virus type II seroprevalence in Africa.
    Bonis J; Verdier M; Dumas M; Denis F
    J Infect Dis; 1994 Jan; 169(1):225-7. PubMed ID: 8277189
    [No Abstract]   [Full Text] [Related]  

  • 6. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
    Dipierri JE; Tajima K; Cartier Robirosa L; Sonoda S
    Medicina (B Aires); 1999; 59(6):717-20. PubMed ID: 10752214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
    Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
    Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
    [No Abstract]   [Full Text] [Related]  

  • 8. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China.
    Cao F; Ji Y; Huang R; Lin S
    Vox Sang; 1998; 75(2):154. PubMed ID: 9784671
    [No Abstract]   [Full Text] [Related]  

  • 12. Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.
    Olaleye DO; Bernstein L; Sheng Z; Ekweozor CC; Li XY; Sullivan-Halley J; Rasheed S
    Am J Trop Med Hyg; 1994 Apr; 50(4):479-86. PubMed ID: 8166356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I/II seroprevalence in The Gambia: a study of mother-child pairs.
    Del Mistro A; Chotard J; Hall AJ; Fortuin M; Whittle H; De Rossi A; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1994 May; 10(5):617-20. PubMed ID: 7917523
    [No Abstract]   [Full Text] [Related]  

  • 14. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
    J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of human T-lymphotropic virus types I and II among the Wayuu Indians from the Guajira Region of Colombia.
    Dueńas-Barajas E; Bernal JE; Vaught DR; Briceño I; Durán C; Yanagihara R; Gajdusek DC
    AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1851-5. PubMed ID: 1489574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural Cameroon.
    Machuca A; Wood O; Lee S; Daniel S; Rios M; Wolfe ND; Carr JK; Eitel MN; Tamoufe U; Torimiro JN; Burke D; Hewlett IK
    Clin Infect Dis; 2005 Jun; 40(11):1673-6. PubMed ID: 15889367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.